HNL — Dr Hoenle AG Income Statement
0.000.00%
Last trade - 00:00
- €120.63m
- €167.32m
- €106.34m
- 50
- 25
- 57
- 37
2019 September 30th | 2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108 | 93.9 | 115 | 116 | 106 |
Cost of Revenue | |||||
Gross Profit | 72.8 | 60.5 | 69.3 | 63.4 | 53.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 90.7 | 85.8 | 115 | 110 | 116 |
Operating Profit | 17 | 8.1 | 0.349 | 5.84 | -9.42 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 16.9 | 7.85 | -0.608 | 4.42 | -11 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.4 | 5.61 | -4.86 | 2.83 | -11.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 12.5 | 5.68 | -4.82 | -13.4 | -11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 12.5 | 5.68 | -4.82 | -13.4 | -11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.27 | 1.06 | -0.816 | 0.258 | -1.86 |
Dividends per Share |